1. Home
  2. Live Updates
  3. Dexcom inc

Live Breaking News & Updates on Dexcom inc

Stay informed with the latest breaking news from Dexcom inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dexcom inc and stay connected to the pulse of your community

Trinity transforming into CGM player with $12.5M acquisition, Bayer partnership

Trinity Biotech plc. paid $12.5 million to acquire Waveform Technologies Inc.’s biosensor and continuous glucose monitoring (CGM) assets. It also formed a partnership with Bayer AG to launch a CGM biosensor in China and India. These moves are part of Trinity’s transformation strategy to become a leading player in wearable biosensor technology.

China , India , Waveform-technologies-inc , Bayer-ag , Trinity-biotech , Waveform-technologies , Bioworld-medtech , Abbott-laboratories , Abbott-laboratories-inc- , Cgm , Continuous-glucose-monitoring

GLP-1 not all loss, sweet side emerges for med tech

Investors bailed on many med-tech companies last year, fearing that the frenzy surrounding GLP-1 agonists would tank companies in the weight-loss, diabetes and orthopedics segments. Their concerns now appear overblown in many instances, with some of the most directly affected businesses reporting a “rising tide” associated with an increased focus on obesity treatment that has lifted their boats rather than sinking them.

Bioworld-medtech , Zimmer-biomet-holdings-inc- , Stryker-corp- , Abbott-laboratories-inc- , Dexcom-inc- , Reshape-lifesciences-inc- , Insulet-corp- , Tandem-diabetes-care-inc- , Allurion-technologies-inc- , Glp-1 , Endocrine-metabolic

Charts turn bullish on health-care stocks as sector takes early lead in 2024

Health-care stocks are off to a strong start in 2024, and Wall Street analysts are taking notice.

Jeff-degraaf , Novo-nordisk-ozempic , Jonathan-krinsky , Danaher-corp , Reuters , Abbvie-inc , Viatris-inc , Health-care-select-sector , Dow-jones , Unitedhealth-group-inc , Mckesson-corp , Wall-street

Vicentra launches hybrid closed-loop diabetes system

With hybrid closed-loop systems for automated insulin delivery increasingly being seen as life changing for people with diabetes, Vicentra BV has teamed up with Diabeloop SA and Dexcom Inc. to launch a system to help people with type 1 diabetes manage their condition.

Dexcom-inc , Dexcom-inc- , Diabeloop-sa , Continuous-glucose-monitoring , Cgm , Type-1-diabetes , Vicentra-bv , Kaleido , Medtronic-plc , Insulin , Insulin-pumps

Diabetes stocks are surprise winners from Novo Nordisk's Wegovy study, analysts say

Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits

Denmark , Danish , Eli-lilly , Novo-nordisk , Raymond-james , Drug-administration , Intuitive-surgical-inc , Dexcom-inc , Davita-inc , Insulet-corp , Leerink-partners , Intuitive-surgical

Diabetes stocks jump as analysts see obesity-drug recovery ahead of schedule

DexCom's strong quarterly results give device makers a boost.

Kevin-sayer , Insulet-corp , Tandem-diabetes-care-inc , Dexcom-inc , Tandem-diabetes-care , Novo-nordisk , Article-normal , Pharmaceuticals , Medical-equipment-supplies , Port-harbor-operations , Healthcare-life-sciences

Glucose monitor maker DexCom's stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness grows

Shares of DexCom Inc. shot up 15.3% to pace the S&P 500’s after-hours gainers on Thursday, after of maker of glucose monitoring systems reported...

Dexcom-inc , Article-normal , Health-care , Corporate-industrial-news , Consumer-affairs , Health , Equity-markets , Dexcom-inc- , Dxcm , Spx , S-amp-ampp-500-index

Dexcom reveals new data showing benefits of CGM, in the long-term and for pregnant women

Dexcom Inc. revealed new clinical data at the European Association for the Study of Diabetes (EASD) which highlighted the benefits of the use of continuous glucose monitoring (CGM). Results from the COMISAIR seven-year study, the longest prospective real-world CGM trial ever conducted, showed significant and continued reduction of HbA1c with the use of real-time CGM by people with type 1 diabetes.

Dexcom-inc , European-association-for-the-study-of-diabetes , European-association , Diabetes , Gestational-diabetes , Cgm , Continuous-glucose-monitoring , Dexcom-inc- ,

These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say

DexCom could be the first stock to break out of ‘GLP jail,’ analysts say, as market continues to punish device makers

Hamburg , Germany , Raymond-james , Dexcom-inc , Tandem-diabetes-care-inc , European-association-for-the-study-of-diabetes , Systems-inc , Insulet-corp , Novo-nordisk , Eli-lilly , Inspire-medical-systems , Freestyle-libre

Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.

Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as...

Wall-street , Article-normal , Textiles , Fiber-yarn-thread , Airlines , Passenger-airlines , Port-harbor-operations , Computer-services , Audiovisual-production , Television-program-production , Air-transport